Abstract

BST-2 blocks the particle release of various enveloped viruses including HIV-1, and this antiviral activity is dependent on the topological arrangement of its four structural domains. Several functions of the cytoplasmic tail (CT) of BST-2 have been previously discussed, but the exact role of this domain remains to be clearly defined. In this study, we investigated the impact of truncation and commonly-used tags addition into the CT region of human BST-2 on its intracellular trafficking and signaling as well as its anti-HIV-1 function. The CT-truncated BST-2 exhibited potent inhibition on Vpu-defective HIV-1 and even wild-type HIV-1. However, the N-terminal HA-tagged CT-truncated BST-2 retained little antiviral activity and dramatically differed from its original protein in the cell surface level and intracellular localization. Further, we showed that the replacement of the CT domain with a hydrophobic tag altered BST-2 function possibly by preventing its normal vesicular trafficking. Notably, we demonstrated that a positive charged motif “KRXK” in the conjunctive region between the cytotail and the transmembrane domain which is conserved in primate BST-2 is important for the protein trafficking and the antiviral function. These results suggest that although the CT of BST-2 is not essential for its antiviral activity, the composition of residues in this region may play important roles in its normal trafficking which subsequently affected its function. These observations provide additional implications for the structure-function model of BST-2.

Highlights

  • The human immunodeficiency virus type 1 (HIV-1) exploits numerous positively acting cellular factors and pathways to maximize viral particle production [1]

  • Terminal cytoplasmic region of BST-2, we studied the impact of its truncation on the antiviral function and other characteristics of this protein

  • According to our preliminary data of N-terminal HA tagged cytoplasmic tail (CT)-truncated BST-2, either Myc, Flag or HA random (RD) tags was fused to the N-terminus of BST-2 DN20 to test the different effects

Read more

Summary

Introduction

The human immunodeficiency virus type 1 (HIV-1) exploits numerous positively acting cellular factors and pathways to maximize viral particle production [1]. Mammalian cells have multiple systems to suppress virus replication through the actions of innate host cell restriction factors [2]. Several host cell restriction factors have been identified that impact specific steps in the HIV-1 lifecycle. These are the APOBEC3 family of proteins [3], BST-2 [4,5,6], TRIM5a [7,8,9] and SAMHD1 [10,11]. Viruses in turn have evolved to express adaptor molecules that antagonize these host cell restrictions, thereby allowing their replication to proceed efficiently. The Vpu protein relieves the host restriction imposed by BST-2

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.